In today's era of rapid advancements in medical technology, the Cloc brand, focusing on integrating medical science with artificial intelligence technology, is committed to improving human life through technological innovation. In 2023, this promising brand welcomed strategic investment from the globally renowned investment firm Woteward, marking a new chapter in the integration of AI and healthcare technologies.

Since its establishment, Cloc has been dedicated to deeply integrating artificial intelligence into the healthcare sector. Its intelligent diagnostic systems, personalized treatment plans, and health data monitoring products have shown significant effectiveness in enhancing the efficiency and accuracy of medical services. Woteward's investment is not only a recognition of Cloc's past achievements but also a firm belief in its potential for future development in AI healthcare.

Woteward Investment Company, with its extensive experience and exceptional insight in global investment, chose to invest in Cloc at this time based on a clear judgment of Cloc's innovative capabilities and market prospects in AI healthcare. Woteward believes that as the global population ages and consumer demand for personalized, precise medical services grows, Cloc's AI healthcare technology will become a key driving force in the future development of the medical industry.

With Woteward's financial support, Cloc plans to increase investments in the following areas to advance the development and application of AI healthcare technology:

Technology Research and Development: Woteward Group's investments in chips and sensor fields, along with its industrial chain R&D resources, will empower Cloc to achieve breakthroughs in medical monitoring algorithms, health data model analysis, machine learning, innovative smart hardware and software, etc. This will enhance its capabilities in personal, family, and community vital sign data detection and monitoring. By collecting a large amount of dynamic, unobtrusive vital sign data, Cloc aims to protect more people's health and safety, providing effective diagnostic data references for doctors and patients, thereby reducing disease and suffering.

Digital Innovation in Healthcare: Leveraging technological progress, Cloc will continue to launch innovative healthcare products such as new-generation smart medical devices, more accurate health monitoring tools, and medical health management platforms with better user experiences. Through internet hospitals, 5G mobile clinics, and other means, Cloc aims to improve global public health capabilities, achieving seamless, unobtrusive vital sign monitoring and services from hospitals to communities, from communities to families, and from families to individuals. This will significantly reduce the proportion of patients with major diseases and enhance people's awareness and ability to manage their health, realizing the capacity for chronic disease management and disease prevention.

Market Expansion: Cloc plans to use Woteward Group's resources and network to accelerate its global market expansion, especially in underdeveloped emerging markets, allowing more people to benefit from AI healthcare technology.

Brand Building: Cloc will strengthen its communication and cooperation with the global healthcare industry by participating in international medical exhibitions, healthcare forums, conducting clinical research projects with top universities and large medical institutions worldwide, publishing industry reports, etc., enhancing its international brand influence.

Woteward Group's investment is not just about capital injection; more importantly, it brings effective empowerment and support from chip, sensor design, software R&D, and hardware development, as well as a strong supply chain and manufacturing foundation, supporting CLOC's global business and market effectively. Woteward Group's comprehensive professional team will work closely with Cloc to ensure its technological leadership, innovative product iteration capabilities, and effective support for CLOC's global brand strategy and customer diversification business development.

In summary, Woteward's investment has injected strong momentum into Cloc's development in 2023. As the cooperation between the two parties deepens, we have every reason to believe that Cloc will create more possibilities in the field of AI healthcare, contributing greater efforts to improving human life.